PT  - JOURNAL ARTICLE
AU  - Bander Ali Aldamkh
AU  - Abdalaziz F. Alamer
AU  - Mohammed M. Altuwaijri
AU  - Mohammed A. Alrumayyan
AU  - Abdulaziz H. Alhaqbani
AU  - Nawaf A. Alharthi
AU  - Saeed A. Aldamkh
AU  - Amjad S. Aldrees
AU  - Muhammad T. Alrifai
AU  - Waleed Altuwaijri
AU  - Ahmed Alrumayyan
TI  - Clinical Presentation and outcome of acute disseminated encephalomyelitis in Saudi Arabia
AID  - 10.17712/nsj.2019.2.20180017
DP  - 2019 Apr 01
TA  - Neurosciences Journal
PG  - 89--94
VI  - 24
IP  - 2
4099  - http://nsj.org.sa/content/24/2/89.short
4100  - http://nsj.org.sa/content/24/2/89.full
SO  - Neurosciences (Riyadh)2019 Apr 01; 24
AB  - Objectives: To evaluate the clinical presenation of acute disseminated Encephalomyelitis (ADEM) in pediatric age group, treatments, and to asses the outcome at King Abdulaziz Medical City, Riyadh, Kingdom of Saudia Arabia.Methods: The medical records of all patients younger than 18 years of age with a diagnosis of ADEM and treated at King Abdulaziz Medical City from January 1996 to Decemeber 2016 were collected. A total of 20 patients were included.Results: Of 20 patients enrolled in our study, 13 (65%) were female. Autumn and summer were the most common seasons in which ADEM presented (60%); 19 (95%) patients had a history of preceding viral illnesses. The most common neurological deficits on presentation were weakness (85%), ataxia (45%), and nystagmus (45%). Cortical and subcortical lesions (60%) were the most common finding on cranial magnetic resonance imaging. Seventeen patients (85%) received steroid only. Only 16 patients continued with follow-up, with a mean duration of 7 months. All 16 patients improved: 11 patients were recovered and 5 patients still had a neurological deficit at the clinic visits. No patient had relapsed.Conclusion: Most of the patients in this case series have an excellent outcome and attended follow-up visits and no disease relapses were identified. Further exploration of the disease is recommended.